Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Itai Danovitch; Kyla Truman; Haze Brown; Macie Miller; Shaishav Shah; Jayant Totlani; Daniel N Kaidbay; Kaleab K Tessema; Zholi Minasyan; Waguih William IsHak; Samuel Miles; Robert N Pechnick

doi:10.1007/s40263-026-01334-4

SCHEDA SCIENTIFICA2026Revisione sistematica

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Itai Danovitch, Kyla Truman, Haze Brown, Macie Miller, Shaishav Shah, Jayant Totlani, Daniel N Kaidbay, Kaleab K Tessema, Zholi Minasyan, Waguih William IsHak, Samuel Miles, Robert N Pechnick

CNS drugs · 2026

Psicologia clinica Psicoterapia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansRandomized Controlled Trials as TopicSubstance-Related DisordersSystematic Reviews as TopicClinical Trials, Phase III as TopicDrug Approval

Come citare questo studio

Itai Danovitch, Kyla Truman, Haze Brown, Macie Miller, Shaishav Shah, Jayant Totlani, Daniel N Kaidbay, Kaleab K Tessema, Zholi Minasyan, Waguih William IsHak, Samuel Miles, Robert N Pechnick. (2026). Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.. CNS drugs. DOI: 10.1007/s40263-026-01334-4

Consulta la pubblicazione originale ↗